[
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88255"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Mycosis Fungoides and Sezary Syndrome B1b TNM Finding v7"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88255",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Clone positive.  Note: A T-cell clone is defined by PCR or Southern blot analysis of the T-cell receptor gene.  (from AJCC 7th Ed.)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C88253",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C88253",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C88253",
      "http://purl.obolibrary.org/obo/NCIT_C88249",
      "http://purl.obolibrary.org/obo/NCIT_C88229",
      "http://purl.obolibrary.org/obo/NCIT_C88228",
      "http://purl.obolibrary.org/obo/NCIT_C48233",
      "http://purl.obolibrary.org/obo/NCIT_C48232",
      "http://purl.obolibrary.org/obo/NCIT_C3367",
      "http://purl.obolibrary.org/obo/NCIT_C7057"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C88253",
      "http://purl.obolibrary.org/obo/NCIT_C88249",
      "http://purl.obolibrary.org/obo/NCIT_C88229",
      "http://purl.obolibrary.org/obo/NCIT_C88228",
      "http://purl.obolibrary.org/obo/NCIT_C48233",
      "http://purl.obolibrary.org/obo/NCIT_C48232",
      "http://purl.obolibrary.org/obo/NCIT_C3367",
      "http://purl.obolibrary.org/obo/NCIT_C7057"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88256"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Mycosis Fungoides and Sezary Syndrome B2 TNM Finding v7"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88256",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "High blood tumor burden: 1000/microL Sezary cells or more with positive clone.  Note 1: for blood, Sezary cells are defined as lymphocytes with hyperconvoluted cerebriform nuclei.  If Sezary cells are not able to be used to determine tumor burden for B2, then one of the following modified ISCL criteria along with a positive clonal rearrangement of the TCR may be used instead: (1) expanded CD4+ or CD3+ cells with CD4/CD8 ratio of 10 or more, (2) expanded CD4+ cells with abnormal immunophenotype including loss of CD7 or CD26.  Note 2: A T-cell clone is defined by PCR or Southern blot analysis of the T-cell receptor gene.  (from AJCC 7th Ed.)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C88249",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C88249",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C88249",
      "http://purl.obolibrary.org/obo/NCIT_C88229",
      "http://purl.obolibrary.org/obo/NCIT_C88228",
      "http://purl.obolibrary.org/obo/NCIT_C48233",
      "http://purl.obolibrary.org/obo/NCIT_C48232",
      "http://purl.obolibrary.org/obo/NCIT_C3367",
      "http://purl.obolibrary.org/obo/NCIT_C7057"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C88249",
      "http://purl.obolibrary.org/obo/NCIT_C88229",
      "http://purl.obolibrary.org/obo/NCIT_C88228",
      "http://purl.obolibrary.org/obo/NCIT_C48233",
      "http://purl.obolibrary.org/obo/NCIT_C48232",
      "http://purl.obolibrary.org/obo/NCIT_C3367",
      "http://purl.obolibrary.org/obo/NCIT_C7057"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88257"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Breast Cancer TNM Finding v7"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88257",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A finding about one or more characteristics of breast cancer, following the rules of the TNM AJCC v7 classification system."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C48233",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C48233",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C48233",
      "http://purl.obolibrary.org/obo/NCIT_C48232",
      "http://purl.obolibrary.org/obo/NCIT_C3367",
      "http://purl.obolibrary.org/obo/NCIT_C7057"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C48233",
      "http://purl.obolibrary.org/obo/NCIT_C48232",
      "http://purl.obolibrary.org/obo/NCIT_C3367",
      "http://purl.obolibrary.org/obo/NCIT_C7057"
    ],
    "hasDirectChildren": true,
    "numDescendants": 58,
    "hasHierarchicalChildren": true,
    "numHierarchicalDescendants": 58,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88258"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Breast Cancer Pathologic TNM Finding v7"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88258",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A pathologic finding about one or more characteristics of breast cancer, following the rules of the TNM AJCC v7 classification system. TNM pathologic findings are based on clinical findings supplemented by histopathologic examination of one or more tissue specimens acquired during surgery."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C88257",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C88257",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C88257",
      "http://purl.obolibrary.org/obo/NCIT_C48233",
      "http://purl.obolibrary.org/obo/NCIT_C48232",
      "http://purl.obolibrary.org/obo/NCIT_C3367",
      "http://purl.obolibrary.org/obo/NCIT_C7057"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C88257",
      "http://purl.obolibrary.org/obo/NCIT_C48233",
      "http://purl.obolibrary.org/obo/NCIT_C48232",
      "http://purl.obolibrary.org/obo/NCIT_C3367",
      "http://purl.obolibrary.org/obo/NCIT_C7057"
    ],
    "hasDirectChildren": true,
    "numDescendants": 40,
    "hasHierarchicalChildren": true,
    "numHierarchicalDescendants": 40,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88259"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Resiquimod Topical Gel"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88259",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A topical gel containing the Toll-like receptor (TLR) agonist resiquimod, an imidazoquinolinamine and with potential immunomodulating activity. Resiquimod binds toTLR7 and 8, mainly on dendritic cells, macrophages, and B-lymphocytes, and activates the TLR signaling pathway, resulting in the induction of the nuclear translocation of transcription activator NF-kB and activation of other transcription factors; subsequently, gene expression increases and the production of cytokines increases, especially interferon-alpha (INF-a), resulting in the enhancement of T-helper 1 (Th1) immune responses. In addition, topical application of resiquimod appears to activate epidermal Langerhans cells, leading to an enhanced activation of T-lymphocytes."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C308",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C308",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C8826"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Localized Synovial Sarcoma"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C8826",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Synovial sarcoma that is confined to a specific site without evidence of spread to other anatomic sites."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C189240",
      "http://purl.obolibrary.org/obo/NCIT_C3400"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C189240",
      "http://purl.obolibrary.org/obo/NCIT_C3400"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C189240",
      "http://purl.obolibrary.org/obo/NCIT_C176558",
      "http://purl.obolibrary.org/obo/NCIT_C8576",
      "http://purl.obolibrary.org/obo/NCIT_C36037",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C9305",
      "http://purl.obolibrary.org/obo/NCIT_C9118",
      "http://purl.obolibrary.org/obo/NCIT_C3810",
      "http://purl.obolibrary.org/obo/NCIT_C27574",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C9306",
      "http://purl.obolibrary.org/obo/NCIT_C4867",
      "http://purl.obolibrary.org/obo/NCIT_C3377",
      "http://purl.obolibrary.org/obo/NCIT_C27042",
      "http://purl.obolibrary.org/obo/NCIT_C3400",
      "http://purl.obolibrary.org/obo/NCIT_C6588",
      "http://purl.obolibrary.org/obo/NCIT_C7148"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C189240",
      "http://purl.obolibrary.org/obo/NCIT_C176558",
      "http://purl.obolibrary.org/obo/NCIT_C8576",
      "http://purl.obolibrary.org/obo/NCIT_C36037",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C9305",
      "http://purl.obolibrary.org/obo/NCIT_C9118",
      "http://purl.obolibrary.org/obo/NCIT_C3810",
      "http://purl.obolibrary.org/obo/NCIT_C27574",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C9306",
      "http://purl.obolibrary.org/obo/NCIT_C4867",
      "http://purl.obolibrary.org/obo/NCIT_C3377",
      "http://purl.obolibrary.org/obo/NCIT_C27042",
      "http://purl.obolibrary.org/obo/NCIT_C3400",
      "http://purl.obolibrary.org/obo/NCIT_C6588",
      "http://purl.obolibrary.org/obo/NCIT_C7148"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88260"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "WT1 mRNA-Electroporated Autologous Dendritic Cell Vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88260",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine containing autologous dendritic cells electroporated with full-length mRNA encoding Wilms' tumor 1 (WT1) antigen with potential immunostimulatory and antineoplastic activities. Upon administration, WT1 mRNA-electroporated autologous dendritic cell vaccine may elicit a cytotoxic T-cell (CTL) response against tumor cells expressing WT1. Wt1 is frequently overexpressed in a variety of tumor cell types and often correlates with disease progression and poor prognosis."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C181141",
      "http://purl.obolibrary.org/obo/NCIT_C28310"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C181141",
      "http://purl.obolibrary.org/obo/NCIT_C28310"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C181141",
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C172787",
      "http://purl.obolibrary.org/obo/NCIT_C28310",
      "http://purl.obolibrary.org/obo/NCIT_C28308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C181141",
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C172787",
      "http://purl.obolibrary.org/obo/NCIT_C28310",
      "http://purl.obolibrary.org/obo/NCIT_C28308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88261"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Ad5.SSTR/TK.RGD"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88261",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An RGD-4C-modified, infectivity-enhanced, bicistronic type 5 adenovirus expressing herpes simplex virus thymidine kinase (HSV-tk) gene, a therapeutic suicide gene, and the somatostatin receptor type 2 (SSTR2) gene with potential antineoplastic activity. Modification with the double cyclic peptide RGD-4C allows the virus to bind to cellular integrins, frequently expressed on the surfaces of ovarian cancer cells, instead of the coxsackie and adenovirus (CAR) receptor, which is often nonfunctional in ovarian cancer cells. Upon intratumoral administration, Ad5.SSTR/TK.RGD transfects tumor cells and expresses the HSV-tk gene. After subsequent administration of a synthetic acyclic guanosine analogue prodrug like ganciclovir (GCV), expressed HSV-tk phosphorylates and activates the prodrug, which may result in inhibition of DNA synthesis and apoptosis in HSV-tk-expressing cancer cells. Additionally, as a bystander effect, adjacent non-transfected cells may be killed by the activated antiviral drug. SSTR2 expression allows imaging of gene transfer into tumor cells using a radiolabeled somatostatin analogue."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C204256",
      "http://purl.obolibrary.org/obo/NCIT_C61199"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C204256",
      "http://purl.obolibrary.org/obo/NCIT_C61199"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C204256",
      "http://purl.obolibrary.org/obo/NCIT_C61199"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C204256",
      "http://purl.obolibrary.org/obo/NCIT_C61199"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88262"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Sodium Bicarbonate Solution"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88262",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An aqueous oral mouthwash solution containing the monosodium salt of carbonic acid with alkalinizing and antimucositis activities. Upon introduction into the mouth, the sodium bicarbonate dissociates, forming sodium and bicarbonate ions, which buffer excess hydrogen ion and elevates the oral pH. An alkaline oral environment is less prone to colonization with yeast and aciduric bacteria. In addition, this solution may help relieve mucositis and mucositis-induced pain by diluting human saliva, and cleansing and lubricating mucosal tissues of the mouth, tongue and oropharynx."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C26170",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C26170",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C26170",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C26170",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88263"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Fluorine F 18 Fluoro Furanyl Norprogesterone"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88263",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The progesterone derivative fluoro furanyl norprogesterone (FFNP), radiolabeled with fluorine F 18, with positron-emitting radioligand activity. Upon injection, fluorine F 18 fluoro furanyl norprogesterone (F18-FFNP) binds to progesterone receptors (PgR) in progesterone-responsive tissues. In PgR-positive breast cancer, positron emission tomography (PET) may then be used to quantitate hormone receptor status."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C2124",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C2124",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88264"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "C-VISA BikDD:Liposome"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88264",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A formulation composed of DOTAP:cholesterol liposome nanoparticles complexed with the plasmid C-VISA BiKDD, with potential antineoplastic activity. C-VISA BikDD: liposome consists of a pancreatic-cancer-specific expression vector VISA (VP16-GAL4-WPRE integrated systemic amplifier) and a pancreatic-cancer-specific promoter CCKAR (cholecystokinin type A receptor) (CCKAR-VISA or C-VISA) which drives expression of the gene BikDD, a mutant form of the potent proapoptotic gene Bik (Bcl-2 interacting killer). Upon administration and transduction into pancreatic tumor cells, expression of BikDD by C-VISA BikDD:liposome may induce pancreatic tumor cell apoptosis and suppress pancreatic tumor cell proliferation. BikDD binds with greater affinity to anti-apoptotic proteins bcl-2, bcl-xl, bcl-w and Mcl-1 and is more potent than wild-type Bik. DOTAP:cholesterol liposome is composed of cationic lipid dioleoyl-trimethylammonium propane (DOTAP) and cholesterol at molar ratio of 1:1."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C61199"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C61199"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C61199"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C61199"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88265"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Fluorine F 18 ISO-1"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88265",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A radioconjugate consisting of the benzamide ligand ISO-1 labeled with the radioisotope fluorine F18 with positron-emitting radioisotope activity. Upon administration, fluorine [F18]ISO-1 binds to sigma-2 receptors, located on tumor cells, allowing visualization of sigma-2 receptor-expressing tumor cells with positron emission tomography (PET). Sigma-2 receptors, expressed in a variety of normal healthy tissues such as liver, kidneys, endocrine glands, and in the central nervous system, may be overexpressed in tumor cells."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C2124",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C2124",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88266"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "CD19CAR-CD3zeta-expressing Autologous T lymphocytes"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88266",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Autologous T-lymphocytes transduced with a modified lentiviral vector expressing a chimeric antigen receptor (CAR) consisting of an anti-CD19 scFv (single chain variable fragment) and the zeta chain of the TCR/CD3 complex (CD3-zeta), with potential immunomodulating and antineoplastic activities. Upon transfusion, CD19CAR-CD3zeta-expressing autologous T-lymphocytes are directed to CD19-expressing tumor cells, thereby inducing a selective toxicity only in these tumor cells. The CD19 antigen is a B-cell specific cell surface antigen expressed in all B-cell lineage malignancies. CD3-zeta (or CD247) is a transmembrane signaling adaptor polypeptide that regulates the assembly of complete T-cell receptor complexes and their expression on the cell surface."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C176018",
      "http://purl.obolibrary.org/obo/NCIT_C200766"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C176018",
      "http://purl.obolibrary.org/obo/NCIT_C200766"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C176018",
      "http://purl.obolibrary.org/obo/NCIT_C129826",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C142078",
      "http://purl.obolibrary.org/obo/NCIT_C137999",
      "http://purl.obolibrary.org/obo/NCIT_C154231",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C200766",
      "http://purl.obolibrary.org/obo/NCIT_C28681"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C176018",
      "http://purl.obolibrary.org/obo/NCIT_C129826",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C142078",
      "http://purl.obolibrary.org/obo/NCIT_C137999",
      "http://purl.obolibrary.org/obo/NCIT_C154231",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C200766",
      "http://purl.obolibrary.org/obo/NCIT_C28681"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88267"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "VEGFR Inhibitor KRN951"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88267",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally bioavailable quinoline-urea derivative inhibitor of vascular endothelial growth factor receptors (VEGFRs) 1 and 2 with potential antiangiogenesis and antineoplastic activities. VEGFR inhibitor KRN951 inhibits VEGF-induced phosphorylation of VEGFRs 1 and 2, which may result in inhibition of migration, proliferation and survival of endothelial cells, microvessel formation, the inhibition of tumor cell proliferation, and tumor cell death. Expression of VEGFRs may be upregulated in a variety of tumor cell types."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C93259"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C93259"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C93259",
      "http://purl.obolibrary.org/obo/NCIT_C163953",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C1967",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C93259",
      "http://purl.obolibrary.org/obo/NCIT_C163953",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C1967",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88268"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Agaricus blazei Murill Extract"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88268",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A dietary supplement containing an extract of the Basidiomycete fungus Agaricus blazei Murill with potential chemopreventive, antineoplastic and immunopotentiating activities. Agaricus blazei Murill extract contains high levels of phytochemicals, especially beta-D-glucans. Beta-D-glucans may promote dendritic cell (DC) maturation; increase interferon gamma (IFN-gamma), tumor necrosis factor alpha (TNF-alpha) and immunoglobulin levels; and may enhance natural killer (NK) cell activity, potentially boosting anti-tumor host immune responses."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C129820",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C129820",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88269"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "High-Selenium Baker's Yeast"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88269",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A baker's yeast (Saccharomyces cerevisiae) containing high levels of the trace element selenium (Se) with potential chemopreventive, immunomodulating and antioxidant activities. Selenium is introduced into yeast during fermentation and incorporated into selenocompounds, such as selenomethionine and glutamyl SE methylselenocysteine. Selenium functions as a cofactor for antioxidant enzymes such as glutathione peroxidases and thioredoxin reductase."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C308",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C308",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C8827"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Recurrent Synovial Sarcoma"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C8827",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The reemergence of synovial sarcoma after a period of remission"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C139002",
      "http://purl.obolibrary.org/obo/NCIT_C3400"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C139002",
      "http://purl.obolibrary.org/obo/NCIT_C3400"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C139002",
      "http://purl.obolibrary.org/obo/NCIT_C148302",
      "http://purl.obolibrary.org/obo/NCIT_C4813",
      "http://purl.obolibrary.org/obo/NCIT_C4798",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C9305",
      "http://purl.obolibrary.org/obo/NCIT_C9118",
      "http://purl.obolibrary.org/obo/NCIT_C3810",
      "http://purl.obolibrary.org/obo/NCIT_C27574",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C150536",
      "http://purl.obolibrary.org/obo/NCIT_C4867",
      "http://purl.obolibrary.org/obo/NCIT_C3377",
      "http://purl.obolibrary.org/obo/NCIT_C27042",
      "http://purl.obolibrary.org/obo/NCIT_C9306",
      "http://purl.obolibrary.org/obo/NCIT_C3400",
      "http://purl.obolibrary.org/obo/NCIT_C6588",
      "http://purl.obolibrary.org/obo/NCIT_C7148"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C139002",
      "http://purl.obolibrary.org/obo/NCIT_C148302",
      "http://purl.obolibrary.org/obo/NCIT_C4813",
      "http://purl.obolibrary.org/obo/NCIT_C4798",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C9305",
      "http://purl.obolibrary.org/obo/NCIT_C9118",
      "http://purl.obolibrary.org/obo/NCIT_C3810",
      "http://purl.obolibrary.org/obo/NCIT_C27574",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C150536",
      "http://purl.obolibrary.org/obo/NCIT_C4867",
      "http://purl.obolibrary.org/obo/NCIT_C3377",
      "http://purl.obolibrary.org/obo/NCIT_C27042",
      "http://purl.obolibrary.org/obo/NCIT_C9306",
      "http://purl.obolibrary.org/obo/NCIT_C3400",
      "http://purl.obolibrary.org/obo/NCIT_C6588",
      "http://purl.obolibrary.org/obo/NCIT_C7148"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88270"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Omipalisib"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88270",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A small-molecule pyridylsulfonamide inhibitor of phosphatidylinositol 3-kinase (PI3K) with potential antineoplastic activity. Omipalisib binds to and inhibits PI3K in the PI3K/mTOR signaling pathway, which may trigger the translocation of cytosolic Bax to the mitochondrial outer membrane, increasing mitochondrial membrane permeability and inducing apoptotic cell death. Bax is a member of the proapoptotic Bcl2 family of proteins. PI3K, often overexpressed in cancer cells, plays a crucial role in tumor cell regulation and survival."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C2152"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C2152"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C2152",
      "http://purl.obolibrary.org/obo/NCIT_C1404",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C1742"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C2152",
      "http://purl.obolibrary.org/obo/NCIT_C1404",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C1742"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88271"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "PDK1 Inhibitor AR-12"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88271",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally bioavailable, small-molecule, celecoxib-derived inhibitor of phosphoinositide-dependent kinase-1 (PDK1) with potential antineoplastic activity. Devoid of any COX inhibiting activity, PDK1 inhibitor AR-12 binds to and inhibits the phosphorylation of 3-phosphoinositide-dependent kinase-1 (PDK-1).; subsequently, the phosphorylation and activation of the serine/threonine protein kinase Akt (protein kinase B or PKB) is inhibited, which may result in inhibition of the PI3K/Akt signaling pathway, inhibition of tumor cell proliferation, and the induction of tumor cell apoptosis.  In addition, this agent appears to induce the activity of protein kinase R-like endoplasmic reticulum kinase (PERK), which plays a key role in the endoplasmic reticulum stress pathway. Activation and dysregulation of the PI3K/Akt signaling pathway is frequently associated with tumorigenesis and dysregulated PI3K/Akt signaling may contribute to tumor resistance to a variety of antineoplastic agents."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C1404",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C1404",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1404",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1404",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88272"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Fexagratinib"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88272",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally bioavailable inhibitor of the fibroblast growth factor receptor (FGFR) with potential antineoplastic activity. fexagratinib binds to and inhibits FGFR, which may result in the inhibition of FGFR-related signal transduction pathways, and, so, the inhibition of tumor cell proliferation and tumor cell death. FGFR, up-regulated in many tumor cell types, is a receptor tyrosine kinase essential to tumor cellular proliferation, differentiation and survival."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C155727",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C155727",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C155727",
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C164035",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C1967",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C155727",
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C164035",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C1967",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88273"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "AC480"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88273",
    "type": [
      "class",
      "entity"
    ],
    "isObsolete": true,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C95421",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C95421",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C95421",
      "http://purl.obolibrary.org/obo/NCIT_C28428"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C95421",
      "http://purl.obolibrary.org/obo/NCIT_C28428"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88274"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Smac Mimetic GDC-0152"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88274",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A second mitochondrial activator of caspases (Smac) mimetic inhibitor of IAPs (Inhibitor of Apoptosis Proteins) with potential antineoplastic activity. Smac mimetic GDC-0152 binds to the Smac binding groove on IAPs, including the direct caspase inhibitor X chromosome-linked IAP (XIAP) and the cellular IAPs 1 and 2, which may inhibit their activities and promote the induction of apoptosis through apoptotic signaling pathways.  IAPs are overexpressed by many cancer cell types and suppress apoptosis by binding to and inhibiting active caspases-3, -7 and -9 via their baculoviral lAP repeat (BIR) domains. Smac, the endogenous IAP antagonist, relies on its N-terminal four amino-acid motif for binding to IAPs."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C129839",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C129839",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129839",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129839",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88275"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "THL-P"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88275",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A proprietary, oral Chinese medicinal herb preparation with potential antioxidant, immunomodulating, and antineoplastic activities. THL-P (Tien-Hsien Liquid-P) contains fourteen Chinese medicinal herbs including: Cordyceps sinensis, Oldenlandia diffusa, Indigo pulverata levis, Polyporus umbellatus, Radix astragali, Panax ginseng, Solanum nigrum L., Pogostemon cablin, Atractylodis macrocephalae rhizoma, Trichosanthes radix, Clematis radix, Margarite, Ligustrum lucidum Ait and Glycyrrhiza radix. Administered as an oral liquid, THL-P may modulate the activity of natural killer (NK) cells, cytotoxic T-lymphocytes (CTLs), macrophages and polymorphonuclear leukocytes, and enhance the secretion of interleukins (ILs) and interferon-gamma (IFN-gamma). This agent may also induce G2/M cell cycle arrest and downregulate several important oncogenic signaling pathways."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C1505",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C1505",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1505",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1505",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88276"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Technetium Tc-99m Demobesin-4"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88276",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A radioconjugate composed of the synthetic bombesin (BB) analog demobesin-4 bound to the radioisotope technetium Tc 99m with receptor ligand and gamma-emitting radioisotope activities. Upon intravenous administration, demobesin-4 selectively binds to the gastrin-releasing peptide receptor (GRPR) expressed on the surfaces of various tumor cell types; upon internalization, tumor cells expressing GRPRs bound to technetium Tc 99m can then be visualized using scintigraphy. GRPR, a bombesin receptor subtype, is frequently overexpressed on the surface of tumor cells such as prostate and breast cancer cells. Demobesin-4 was developed for technetium Tc 99m imaging of GRPR-expressing tumor cells."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C2124",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C2124",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88277"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Lutetium Lu 177-Edotreotide"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88277",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A radioconjugate consisting of the somatostatin analogue edotreotide labeled with lutetium Lu 177 with potential antineoplastic activities. Lutetium Lu 177-edotreotide binds to somatostatin receptors (SSTRs), with high affinity to type 2 SSTR, present on the cell membranes of many types of neuroendocrine tumor cells. Upon binding and internalization, this radioconjugate specifically delivers a cytotoxic dose of beta radiation to SSTR-positive cells. Edotreotide is produced by substituting tyrosine for phenylalanine at the 3 position of the somatostatin analogue octreotide (Tyr3-octreotide or TOC) and chelated by the bifunctional, macrocyclic chelating agent dodecanetetraacetic acid (DOTA)."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129819",
      "http://purl.obolibrary.org/obo/NCIT_C2124"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129819",
      "http://purl.obolibrary.org/obo/NCIT_C2124"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129819",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C2124"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129819",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C2124"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88278"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Multikinase Inhibitor SAR103168"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88278",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A multikinase inhibitor with potential antineoplastic activity. Upon intravenous infusion, multikinase inhibitor SAR103168 may, through the inhibition of multiple kinases, inhibit the phosphorylation and activation of signal transducer and activator of transcription 5 (STAT5). STAT5, a protein often upregulated in cancer cells, plays a key role in signal transduction pathways and the suppression of apoptosis."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88279"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "MVA-FCU1 TG4023"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88279",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine comprised of a recombinant modified vaccinia Ankara (MVA) viral vector encoding the suicide gene FCU1 with potential antineoplastic activity. FCU1 is a bifunctional yeast cytosine deaminase (CD) / uracil phosphoribosyltransferase (UPRT) fusion gene. Upon intratumoral administration, MVA-FCU1TG4023 enters tumor cells where FCU1 is expressed. Subsequently, the noncytotoxic prodrug 5-fluorocytosine (5-FC) is administered systemically and is deaminated by CD in FCU1- transduced tumor cells into 5-fluorouracil (5-FU), which is then directly metabolized to 5-fluoro-uridine monophosphate (5-FUMP) by UPRT; 5-FUMP may then be further transformed to 5-fluoro-deoxyuridine monophosphate (5-FdUMP), an irreversible inhibitor of thymidylate synthase and, so, DNA synthesis through deprivation of deoxythymidine triphosphate (dTTP). 5-FU and its active metabolites may then selectively kill tumor cells, avoiding toxicity in nonmalignant cells. The MVA viral vector, derived from the replication-competent strain Ankara, is a highly attenuated, replication-defective vaccinia strain incapable of virion assembly."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C2313"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C2313"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C2313",
      "http://purl.obolibrary.org/obo/NCIT_C1572",
      "http://purl.obolibrary.org/obo/NCIT_C96404",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C2313",
      "http://purl.obolibrary.org/obo/NCIT_C1572",
      "http://purl.obolibrary.org/obo/NCIT_C96404",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C8828"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Recurrent Hodgkin's Disease Lymphocyte Predominance Type"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C8828",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An antiquated term that refers to the reemergence of either nodular lymphocyte predominant Hodgkin lymphoma or lymphocyte-rich classical Hodgkin lymphoma after a period of remission."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C8590",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C8590",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C8590",
      "http://purl.obolibrary.org/obo/NCIT_C27809",
      "http://purl.obolibrary.org/obo/NCIT_C7340",
      "http://purl.obolibrary.org/obo/NCIT_C45230",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C8590",
      "http://purl.obolibrary.org/obo/NCIT_C27809",
      "http://purl.obolibrary.org/obo/NCIT_C7340",
      "http://purl.obolibrary.org/obo/NCIT_C45230",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88280"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Irinotecan/P-glycoprotein Inhibitor HM30181AK Combination Tablet"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88280",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally bioavailable combination tablet containing the semisynthetic camptothecin derivative irinotecan and the multidrug resistance (MDR) efflux pump P-glycoprotein (P-gp) inhibitor HM30181AK, with potential antineoplastic activity. HM30181A binds to P-gp and prevents the P-gp-mediated efflux of irinotecan from tumor cells, which may result in greater intracellular concentrations of irinotecan and enhanced cytotoxicity. Retained intracellularly, the prodrug irinotecan is converted, by a carboxylesterase-converting enzyme, to the biologically active metabolite 7-ethyl-10-hydroxy-camptothecin (SN-38). SN-38 inhibits topoisomerase I activity by stabilizing the cleavable complex between topoisomerase I and DNA, resulting in DNA breaks that inhibit DNA replication and trigger apoptotic cell death.  P-gp, encoded by the MDR-1 gene, is a member of the ATP-binding cassette (ABC) superfamily of transmembrane transporters and is overexpressed by some MDR tumors, preventing the intracellular accumulation of various cytotoxic agents."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C1904",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C1904",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1904",
      "http://purl.obolibrary.org/obo/NCIT_C1748",
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1904",
      "http://purl.obolibrary.org/obo/NCIT_C1748",
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88281"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Necitumumab"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88281",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A fully human IgG1 monoclonal antibody directed against the epidermal growth factor receptor (EGFR) with potential antineoplastic activity. Necitumumab binds to and blocks the ligand binding site of EGFR, thereby preventing the activation and subsequent dimerization of the receptor. This may lead to an inhibition of EGFR-dependent downstream pathways and so inhibition of EGFR-dependent tumor cell proliferation and metastasis.  EGFR, a member of the epidermal growth factor family of extracellular protein ligands, may be overexpressed on the cell surfaces of various tumor cell types."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C133878"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C133878"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C133878",
      "http://purl.obolibrary.org/obo/NCIT_C163952",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C133878",
      "http://purl.obolibrary.org/obo/NCIT_C163952",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88282"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Antiperspirant Cream F511"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88282",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A cream formulation containing aluminum chlorohydrate with astringent and antiperspirant activities. Upon topical application of F511 cream, aluminium chlorohydrate forms a gel matrix in the sweat gland which subsequently reduces, then stops the flow of water. In addition, this agent exerts an astringent effect, thereby further preventing sweat formation. Hyperhidrosis appears to play a role in the development of certain mucocutaneous reactions, such as palmar-plantar erythrodysesthesia (PPE), upon administration of chemotherapeutic agents such as doxorubicin, 5-fluorouracil, and capecitabine."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C78284",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C78284",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C78284",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C78284",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88283"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Inebilizumab"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88283",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A humanized immunoglobulin IgG1 kappa monoclonal antibody directed against the B-cell-specific membrane protein CD-19 with potential immunostimulating and antineoplastic activities. Inebilizumab binds to CD19, which may result in a cytotoxic T-lymphocyte (CTL) response and antibody-dependent cellular cytotoxicity (ADCC) to CD19-expressing B-cells. The Fc portion of inebilizumab does not contain a fucose sugar moiety, which may contribute to its enhanced ADCC activity. CD19 is a membrane antigen that is widely expressed during B-cell development, from pro-B-cell to early plasma cell stages."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C112889",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C112889",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C112889",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C198634",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C20401"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C112889",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C198634",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C20401"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88284"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Iodine I-124 FIAU"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88284",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A radioconjugate containing the nucleoside analog 2'-fluoro-2'-deoxy-1beta-D-arabinofuranosyl-5-iodouracil (FIAU) labeled with the radioisotope iodine I 124 with positron-emitting activity. Chemotherapeutic agents such as bortezomib may induce viral thymidine kinase expression in EBV- and Kaposi's sarcoma herpesvirus (KSHV)-associated tumors. Subsequent to chemotherapy induction of viral TK in these tumors, administered iodine I 124 FIAU is phosphorylated by expressed viral TK, becoming selectively trapped within TK-expressing tumor cells; these cells can then be visualized with positron emission tomography (PET). Viral TK is either not expressed or is expressed at very low levels in EBV- and Kaposi's sarcoma herpesvirus (KSHV)-associated tumors and may be activated by certain chemotherapeutic agents."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C2124",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C2124",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88286"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Pegylated Recombinant Human Arginase I BCT-100"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88286",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A recombinant human arginase I (liver arginase) covalently attached, via a succinamide propionic acid (SPA) linker, to a polyethylene glycol (PEG) of molecular weight 5,000 [rhArg-peg(5,000mw)] with potential antineoplastic activity. Upon intravenous administration of pegylated recombinant human arginase I BCT-100, arginase metabolizes the amino acid arginine to ornithine and urea, depleting intracellular arginine, which may inhibit proliferation of cells that are auxotrophic for arginine such as hepatocellular carcinoma (HCC) cells.  This agent may also work synergistically with various cytotoxic agents."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C29726",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C29726",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C29726",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C29726",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88287"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Anti-CD45 BC8 Monoclonal Antibody-Streptavidin Conjugate"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88287",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An immunoconjugate containing a monoclonal antibody directed against the CD45 antigen BC8, conjugated to streptavidin, a nonglycosylated homotetrameric protein that has four high affinity binding sites for biotin. Anti-CD45 BC8 antibody-streptavidin conjugate binds to CD45, a transmembrane protein tyrosine phosphatase that is expressed on the surface of normal and malignant hematopoietic cells. Upon administration of a biotin-based radioconjugate, the biotin moiety of the radioconjugate binds to the streptavidin moiety of anti-CD45 BC8 antibody-streptavidin conjugate and, upon cellular internalization, specifically delivers cytotoxic radiation to CD45-expressing tumor cells."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C1512"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C1512"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1512",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1512",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88288"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Zoster Vaccine Recombinant, Adjuvanted"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88288",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A recombinant, subunit herpes zoster (HZ) vaccine containing varicella-zoster virus (VZV) glycoprotein E (gE), that can potentially be used to prevent HZ infection, also called shingles. Upon administration, zoster vaccine recombinant, adjuvanted stimulates the host immune system to induce both specific CD4-positive T-cells and antibodies against VZV gE, thereby protecting against infection with HZ. VZV gE, the most common antigen in VZV viral particles, plays a key role in VZV infection. Compared to live-attenuated vaccines, the subunit vaccine prevents the risk of vaccine-induced HZ in immunocompromised patients."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C1572",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C1572",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1572",
      "http://purl.obolibrary.org/obo/NCIT_C96404",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1572",
      "http://purl.obolibrary.org/obo/NCIT_C96404",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88289"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "pNGVL4a-CRT/E7(detox) DNA Vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88289",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine consisting of the DNA plasmid pNGVL4a-A encoding calreticulin (CRT) linked to a detox form of human papillomavirus (HPV) type 16 E7 antigen, with potential immunomodulating and antineoplastic activities. Upon administration, this vaccine may generate a potent cytotoxic T-lymphocyte (CTL) response against E7-expressing tumor cells, resulting in tumor cell death. For E7(detox), the amino acids in E7 at positions 24 (cysteine to glycine) and 26 (glutamic acid to glycine) were substituted. CRT, a 46 kDa protein located in the lumen of the cell's endoplasmic reticulum (ER), may potentiate MHC class I presentation of HPV-16 E7 to E7-specific CD8-positive T cells. In addition, pNGVL4a-A contains two short immunostimulatory DNA sequences (ISS) in the noncoding region, which may elicit the production of IFN- and IL-12 in transfected keratinocytes and dermal antigen presenting cells (APCs), resulting in a potent T helper cell type 1 response."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C39619"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C39619"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C39619"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C39619"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C8829"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Refractory Hodgkin's Disease Lymphocyte Predominance Type"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C8829",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An antiquated term that refers either to nodular lymphocyte predominant Hodgkin lymphoma or to lymphocyte-rich classical Hodgkin lymphoma that is resistant to treatment."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C8590",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C8590",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C8590",
      "http://purl.obolibrary.org/obo/NCIT_C27809",
      "http://purl.obolibrary.org/obo/NCIT_C7340",
      "http://purl.obolibrary.org/obo/NCIT_C45230",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C8590",
      "http://purl.obolibrary.org/obo/NCIT_C27809",
      "http://purl.obolibrary.org/obo/NCIT_C7340",
      "http://purl.obolibrary.org/obo/NCIT_C45230",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88290"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Short Chain Fatty Acid HQK-1004"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88290",
    "type": [
      "class",
      "entity"
    ],
    "isObsolete": true,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C192094",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C192094",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C192094",
      "http://purl.obolibrary.org/obo/NCIT_C28428"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C192094",
      "http://purl.obolibrary.org/obo/NCIT_C28428"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88291"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "EGFR Inhibitor PF-00299804"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88291",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. EGFR inhibitor PF-00299804 specifically and irreversibly binds to and inhibits human EGFR subtypes, resulting in inhibition of proliferation and induction of apoptosis in EGFR-expressing tumor cells. EGFRs play major roles in tumor cell proliferation and tumor vascularization, and are often overexpressed or mutated in various tumor cell types."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": true,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C95421",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C95421",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C95421",
      "http://purl.obolibrary.org/obo/NCIT_C28428"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C95421",
      "http://purl.obolibrary.org/obo/NCIT_C28428"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88292"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Indium In 111 Capromab Pendetide"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88292",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A radioimmunoconjugate consisting of the murine IgG1 kappa monoclonal antibody capromab (7E11-C5.3), conjugated to the linker-chelator glycyl-tyrosyl-(N,-diethylenetriaminepentaacetic acid)-lysine hydrochloride (GYK-DTPA-HCl) and labeled with radioisotope indium In 111, with ligand-binding and gamma-emitting activities. Upon intravenous administration, indium In 111-capromab pendetide binds to a cytoplasmic epitope of human prostate specific membrane antigen (PSMA) expressed on prostate tumor cell surfaces via its capromab moiety and, upon internalization, allows radioimmunolocalization with gamma scintigraphy. PSMA is a cell surface glycoprotein abundantly expressed by prostate epithelium and is typically overexpressed by prostate cancer cells."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C2124",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C2124",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88293"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Fedratinib"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88293",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally bioavailable, small-molecule, ATP-competitive inhibitor of Janus-associated kinase 2 (JAK2) and FMS-like tyrosine kinase 3 (FLT3; CD135; STK1; FLK2), with potential antineoplastic activity. Upon oral administration, fedratinib competes with wild-type JAK2 as well as mutated forms for ATP binding, which may result in inhibition of JAK2 activation, inhibition of the JAK-STAT signaling pathway, inhibition of tumor cell proliferation and induction of tumor cell apoptosis. JAK2 is the most commonly mutated gene in bcr-abl-negative myeloproliferative disorders (MPDs). In addition, fedratinib targets, binds to and inhibits the activity of FLT3. This inhibits uncontrolled FLT3 signaling and results in the inhibition of proliferation in tumor cells overexpressing FLT3. FLT3, a class III receptor tyrosine kinase (RTK), is overexpressed or mutated in most B-lineage neoplasms and in acute myeloid leukemias and plays a key role in tumor cell proliferation."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C125450",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C125450",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C125450",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C172200",
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C1967",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C125450",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C172200",
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C1967",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88294"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Bimatoprost Ophthalmic Solution"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88294",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A sterile ophthalmic solution containing 0.03% of a synthetic prostaglandin analog bimatoprost with hair-growing and anti-glaucoma activities. Applied once daily to the upper eyelid margin at the base of the eyelashes and, optionally, to the eyebrows, bimatoprost penetrates into the hair follicle and may, through a mechanism that has yet to be fully understood, stimulate the transition of hair follicles from the telogen phase into the anagen phase and may increase the duration of the time follicles spend in anagen. By increasing the numbers of hair follicles in and duration of anagen phase, bimatoprost may help increase eyebrow and eyelash growth and appearance, including their length, thickness and darkness."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C78568",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C78568",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C78568",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C78568",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88295"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Birinapant"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88295",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A synthetic small molecule that is both a peptidomimetic of second mitochondrial-derived activator of caspases (SMAC) and inhibitor of IAP (Inhibitor of Apoptosis Protein) family proteins, with potential antineoplastic activity. As a SMAC mimetic and IAP antagonist, birinapant selectively binds to and inhibits the activity of IAPs, such as X chromosome-linked IAP (XIAP) and cellular IAPs 1 (cIAP1) and 2 (cIAP2), with a greater effect on cIAP1 than cIAP2. Since IAPs shield cancer cells from the apoptosis process, this agent may restore and promote the induction of apoptosis through apoptotic signaling pathways in cancer cells and inactivate the nuclear factor-kappa B (NF-kB)-mediated survival pathway. IAPs are overexpressed by many cancer cell types. They are able to suppress apoptosis by binding to, via their baculoviral lAP repeat (BIR) domains, and inhibiting active caspases-3, -7 and -9. IAP overexpression promotes both cancer cell survival and chemotherapy resistance."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C129839",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C129839",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129839",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129839",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88296"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Dalantercept"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88296",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A soluble fusion protein containing the extracellular domain of activin receptor-like kinase-1 (ALK1) fused to a human Fc domain (ALK1-Fc fusion protein), with potential antiangiogenic and antineoplastic activities. Upon administration, dalantercept binds to various ALK1 ligands, preventing activation of tumor cell ALK1 receptors and so inhibiting the ALK1 signaling pathway; growth factor-induced angiogenesis is thus inhibited, which may result in the inhibition of tumor cell proliferation and tumor cell death. ALK1 is a type I cell surface receptor with serine/threonine kinase activity that mediates signaling by members of the transforming growth factor-beta (TGFbeta) superfamily and plays a key role in angiogenesis; ligands for this receptor include TGFbeta1 and TGFbeta2. The Fc moiety of this fusion protein mediates clearance of ligand-fusion protein complexes by the reticuloendothelial system (RES)."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C1742",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C1742",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88298"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Carvedilol Phosphate Extended-Release Capsule"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88298",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An extended-release capsule formulation containing the phosphate salt of carvedilol, a nonselective beta-adrenergic blocking agent with alpha 1-adrenergic blocking activity. Carvedilol is a racemic mixture; the S(-) enantiomer non-selectively binds to and blocks beta-adrenergic receptors, exerting negative inotropic and chronotropic effects, leading to a reduction in cardiac output. Both R(+) and S(-) enantiomers bind to and block alpha 1-adrenergic receptors with equal potency, causing vasodilation and a reduction in peripheral vascular resistance. This agent has no intrinsic sympathomimetic activity."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C72900",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C72900",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C72900",
      "http://purl.obolibrary.org/obo/NCIT_C29747",
      "http://purl.obolibrary.org/obo/NCIT_C78272",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C72900",
      "http://purl.obolibrary.org/obo/NCIT_C29747",
      "http://purl.obolibrary.org/obo/NCIT_C78272",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88299"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Ramosetron Hydrochloride"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88299",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The hydrochloride salt of ramosetron, a selective serotonin (5-HT) receptor antagonist with potential antiemetic activity. Upon administration, ramosetron selectively binds to and blocks the activity of 5-HT subtype 3 (5-HT3) receptors located in the vagus nerve terminal and in the vomiting center in the central nervous system (CNS), suppressing chemotherapy-induced nausea and vomiting."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C94726",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C94726",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C94726",
      "http://purl.obolibrary.org/obo/NCIT_C66885",
      "http://purl.obolibrary.org/obo/NCIT_C78272",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C94726",
      "http://purl.obolibrary.org/obo/NCIT_C66885",
      "http://purl.obolibrary.org/obo/NCIT_C78272",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C883"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Recombinant Thymosin"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C883",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A recombinant form of a polypeptide chemically identical to or similar to the hormone secreted by the thymus gland. Thymosin is generally known to have functions in the preprocessing of T cells and the development of B cells to plasma cells to produce antibodies. In particular, the predominant form of thymosin, beta 4 thymosin, is the principal actin-sequestering protein that plays an important role in functions that involve actin molecules, such as maintenance of cell shape, cytoplasmic organization, cell movement, and cell division."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C548"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C548"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C548",
      "http://purl.obolibrary.org/obo/NCIT_C147908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C548",
      "http://purl.obolibrary.org/obo/NCIT_C147908"
    ],
    "hasDirectChildren": true,
    "numDescendants": 2,
    "hasHierarchicalChildren": true,
    "numHierarchicalDescendants": 2,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C8830"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Stage III Hodgkin's Disease Lymphocyte Predominance Type"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C8830",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Stage III adult Hodgkin disease means the involvement of lymph node regions on both sides of the diaphragm (III), which may also be accompanied by localized involvement of an associated extralymphatic organ or site (IIIE), by involvement of the spleen (IIIS), or by involvement of both (IIIE + S). Stage III disease may be subdivided by anatomic distribution of abdominal involvement or by extent of splenic involvement. Stage III(1) indicates involvement that is limited to the upper abdomen above the renal vein. Stage III(2) indicates involvement of pelvic and/or para-aortic nodes. Five or more visible splenic nodules on a cut section constitutes extensive splenic involvement. Zero to four nodules is classified as minimal splenic disease. (from PDQ)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C8590",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C8590",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C8590",
      "http://purl.obolibrary.org/obo/NCIT_C27809",
      "http://purl.obolibrary.org/obo/NCIT_C7340",
      "http://purl.obolibrary.org/obo/NCIT_C45230",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C8590",
      "http://purl.obolibrary.org/obo/NCIT_C27809",
      "http://purl.obolibrary.org/obo/NCIT_C7340",
      "http://purl.obolibrary.org/obo/NCIT_C45230",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88300"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Tomato-Soy Juice"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88300",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A juice containing tomato extract and soy protein with potential chemopreventive and antiproliferative activities. Tomato-soy juice contains phytochemicals, including flavonoids, such as the soy isoflavone genistein, and carotenoids, including lycopene. These phytochemicals may exhibit antioxidative activity, antitumor activity by modulating certain tumor-associated signal transduction pathways, and apoptosis-inducing activity."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C65141",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C65141",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C65141",
      "http://purl.obolibrary.org/obo/NCIT_C62695",
      "http://purl.obolibrary.org/obo/NCIT_C1949",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C65141",
      "http://purl.obolibrary.org/obo/NCIT_C62695",
      "http://purl.obolibrary.org/obo/NCIT_C1949",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  }
]